• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Dogs have the ability to detect COVID-19 in humans, according to a new French study

By
Corinne Gretler
Corinne Gretler
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Corinne Gretler
Corinne Gretler
and
Bloomberg
Bloomberg
Down Arrow Button Icon
May 19, 2021, 9:45 AM ET

Dogs are able to detect COVID-19 in humans, a new study showed, paving the way for the broader use of sniffing canines in a global effort to contain the pandemic.

The dogs’ detection reached 97% sensitivity in the French study, meaning that’s how well the canines could identify positive samples. The sniffing was also 91% specific, which rates the dogs’ ability to identify negatives. The sensitivity rating beats that of many 15-minute antigen tests, which tend to be better at ruling out infection than at finding it.

The results mean that virus-sniffing dogs could be more widely deployed in airports, train stations or wherever crowds amass to screen people, much like they’re used for detecting drugs or bombs. Using dogs also means COVID could be identified at just a fraction of a second in a non-invasive manner, and at a low cost.

The trial, which was conducted at France’s National Veterinary School in Maisons Alfort near Paris, collected sweat samples from the armpits of the participants with cotton pads that were locked into jars and gave them to at least two different dogs for sniffing. None of the dogs had prior contact with the volunteers. There were 335 people tested, of which 109 were positive in a PCR test that served as a control. Nine dogs participated, and the researchers didn’t know which samples were positive.

In July, German researchers showed trained dogs were able to distinguish between saliva sampled from people infected with the virus and those who were not more than 90% of the time. Finland, Dubai and Switzerland have started training dogs to sniff out infections.

The latest study was conducted between March 16 and April 9, and the Ile-de-France region helped fund the trial, contributing 25,000 euros ($30,500).

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.
About the Authors
By Corinne Gretler
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.